PLGA-based nanoparticles: an overview of biomedical applications

F Danhier, E Ansorena, JM Silva, R Coco… - Journal of controlled …, 2012 - Elsevier
Poly (lactic-co-glycolic acid)(PLGA) is one of the most successfully developed
biodegradable polymers. Among the different polymers developed to formulate polymeric …

Biocompatibility, biodegradation and biomedical applications of poly (lactic acid)/poly (lactic-co-glycolic acid) micro and nanoparticles

EM Elmowafy, M Tiboni, ME Soliman - Journal of Pharmaceutical …, 2019 - Springer
Background Poly (lactic acid)(PLA) and poly (lactic-co-glycolic acid)(PLGA) are among the
well-documented FDA-approved polymers used for the preparation of safe and effective …

Recent advances in peptide-based subunit nanovaccines

M Skwarczynski, I Toth - Nanomedicine, 2014 - Taylor & Francis
Vaccination is the most efficient way to protect humans against pathogens. Peptide-based
vaccines offer several advantages over classical vaccines, which utilized whole organisms …

Immune system targeting by biodegradable nanoparticles for cancer vaccines

JM Silva, M Videira, R Gaspar, V Préat… - Journal of controlled …, 2013 - Elsevier
The concept of therapeutic cancer vaccines is based on the activation of the immune system
against tumor cells after the presentation of tumor antigens. Nanoparticles (NPs) have …

Advanced biomaterials for cancer immunotherapy

F Yang, K Shi, Y Jia, Y Hao, J Peng… - Acta Pharmacologica …, 2020 - nature.com
Immunotherapy, as a powerful strategy for cancer treatment, has achieved tremendous
efficacy in clinical trials. Despite these advancements, there is much to do in terms of …

Paracoccidioidomycosis: eco-epidemiology, taxonomy and clinical and therapeutic issues

AL Bocca, AC Amaral, MM Teixeira, PK Sato… - Future …, 2013 - Taylor & Francis
Acquired by inhalation of the thermal dimorphic fungi Paracoccidioides spp. conidia,
paracoccidioidomycosis ranges from symptomatic to severe and potentially fatal …

Targeting tumor antigens to dendritic cells using particulate carriers

MD Joshi, WJ Unger, G Storm, Y Van Kooyk… - Journal of Controlled …, 2012 - Elsevier
Dendritic cells play a central role in antigen presentation and generation of cytotoxic T
lymphocyte (CTL) response required for anticancer vaccination. The review focuses on use …

In vivo delivery of peptides and Toll-like receptor ligands by mannose-functionalized polymeric nanoparticles induces prophylactic and therapeutic anti-tumor immune …

JM Silva, E Zupancic, G Vandermeulen… - Journal of Controlled …, 2015 - Elsevier
We hypothesized that the co-entrapment of melanoma-associated antigens and the Toll-like
receptor (TLR) ligands Poly (I: C) and CpG, known to be Th1-immunopotentiators, in …

Applications of nanomaterials as vaccine adjuvants

M Zhu, R Wang, G Nie - Human vaccines & immunotherapeutics, 2014 - Taylor & Francis
Vaccine adjuvants are applied to amplify the recipient's specific immune responses against
pathogen infection or malignancy. A new generation of adjuvants is being developed to …

Biomimetic nanoparticles for DC vaccination: a versatile approach to boost cancer immunotherapy

L Meng, Z Teng, S Yang, N Wang, YH Guan, X Chen… - Nanoscale, 2023 - pubs.rsc.org
Cancer immunotherapy, which harnesses the immune system to fight cancer, has begun to
make a breakthrough in clinical applications. Dendritic cells (DCs) are the bridge linking …